Cancer Research and Treatment

Cancer Research and Treatment Search

> Browse Articles > Search

Head and Neck cancer

Phase II Trial of Combined Durvalumab Plus Tremelimumab with Proton Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Hana Kim, Sehhoon Park, Hyun Ae Jung, Se-Hoon Lee, Keunchil Park, Yong Chan Ahn, Dongryul Oh, Myung-Ju Ahn

Cancer Res Treat. 2023;55(4):1104-1112. Published online May 17, 2023 DOI: https://doi.org/10.4143/crt.2023.502

Web of Science 4 Crossref 5

Gynecologic cancer

Genomic and Transcriptomic Characterization Revealed the High Sensitivity of Targeted Therapy and Immunotherapy in a Subset of Endometrial Stromal Sarcoma

Nan Kang, Yinli Zhang, Shichao Guo, Ran Chen, Fangzhou Kong, Shuchun Wang, Mingming Yuan, Rongrong Chen, Danhua Shen, Jianliu Wang

Cancer Res Treat. 2023;55(3):978-991. Published online February 2, 2023 DOI: https://doi.org/10.4143/crt.2022.1647

Crossref 1

Genitourinary cancer

Neoadjuvant Nivolumab Plus Gemcitabine/Cisplatin Chemotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder

Hongsik Kim, Byong Chang Jeong, Joohyun Hong, Ghee Young Kwon, Chan Kyo Kim, Won Park, Hongryull Pyo, Wan Song, Hyun Hwan Sung, Jung Yong Hong, Se Hoon Park

Cancer Res Treat. 2023;55(2):636-642. Published online October 6, 2022 DOI: https://doi.org/10.4143/crt.2022.343

Web of Science 4 Crossref 5

Genomic Sequencing for Bladder Urothelial Carcinoma and Its Clinical Implications for Immunotherapy

Ryul Kim, Jung Yong Hong, Jeeyun Lee, Ghee Young Kwon, Byong Chang Jeong, Se Hoon Park

Cancer Res Treat. 2022;54(3):894-906. Published online November 17, 2021 DOI: https://doi.org/10.4143/crt.2021.854

Web of Science 5 Crossref 6

Sarcoma

Clinicopathologic Characteristics and Clinical Outcome of Localized Liposarcoma: A Single-Center Experience over 25 Years and Evaluation of PD-L1 Expression

Heejung Chae, Jeong Eun Kim, Wanlim Kim, Jong-Seok Lee, Si Yeol Song, Min Hee Lee, Hye Won Chung, Kyung-Ja Cho, Joon Seon Song, Jin-Hee Ahn

Cancer Res Treat. 2022;54(2):579-589. Published online July 6, 2021 DOI: https://doi.org/10.4143/crt.2021.496

Web of Science 1 Crossref 1

General

Engineering a High-Affinity PD-1 Peptide for Optimized Immune Cell-Mediated Tumor Therapy

Yilei Chen, Hongxing Huang, Yin Liu, Zhanghao Wang, Lili Wang, Quanxiao Wang, Yan Zhang, Hua Wang

Cancer Res Treat. 2022;54(2):362-374. Published online August 3, 2021 DOI: https://doi.org/10.4143/crt.2021.424

Web of Science 4 Crossref 4

Pan-cancer Analysis of Tumor Mutational Burden and Homologous Recombination DNA Damage Repair Using Targeted Next-Generation Sequencing

Hai-Yun Wang, Ling Deng, Ying-Qing Li, Xiao Zhang, Ya-Kang Long, Xu Zhang, Yan-Fen Feng, Yuan He, Tao Tang, Xin-Hua Yang, Fang Wang

Cancer Res Treat. 2021;53(4):973-982. Published online February 18, 2021 DOI: https://doi.org/10.4143/crt.2020.798

Web of Science 6 Crossref 6

Clinical Outcomes of Immune Checkpoint Blocker Therapy for Malignant Melanoma in Korean Patients: Potential Clinical Implications for a Combination Strategy Involving Radiotherapy

Jeongshim Lee, Jee Suk Chang, Mi Ryung Roh, Minkyu Jung, Choong-Kun Lee, Byung Ho Oh, Kee Yang Chung, Woong Sub Koom, Sang Joon Shin

Cancer Res Treat. 2020;52(3):730-738. Published online February 13, 2020 DOI: https://doi.org/10.4143/crt.2019.598

Web of Science 6 Crossref 6

Efficacy and Safety of Pembrolizumab in Patients with Refractory Advanced Biliary Tract Cancer: Tumor Proportion Score as a Potential Biomarker for Response

Junho Kang, Jae Ho Jeong, Hee-Sang Hwang, Sang Soo Lee, Do Hyun Park, Dong Wook Oh, Tae Jun Song, Ki-Hun Kim, Shin Hwang, Dae Wook Hwang, Song Cheol Kim, Jin-hong Park, Seung-Mo Hong, Kyu-pyo Kim, Baek-Yeol Ryoo, Changhoon Yoo

Cancer Res Treat. 2020;52(2):594-603. Published online December 18, 2019 DOI: https://doi.org/10.4143/crt.2019.493

Web of Science 47 Crossref 46

Combination Treatment of Stereotactic Body Radiation Therapy and Immature Dendritic Cell Vaccination for Augmentation of Local and Systemic Effects

Chul Won Choi, Min Ho Jeong, You-Soo Park, Cheol-Hun Son, Hong-Rae Lee, Eun-Kyoung Koh

Cancer Res Treat. 2019;51(2):464-473. Published online June 6, 2018 DOI: https://doi.org/10.4143/crt.2018.186

Web of Science 16 Crossref 14

Pembrolizumab for Refractory Metastatic Myxofibrosarcoma: A Case Report

Haa-Na Song, Min Gyu Kang, Jeong Rang Park, Jin-Yong Hwang, Jung Hun Kang, Won Seop Lee, Gyeong-Won Lee

Cancer Res Treat. 2018;50(4):1458-1461. Published online January 22, 2018 DOI: https://doi.org/10.4143/crt.2017.529

Web of Science 13 Crossref 12

Ipilimumab Real-World Efficacy and Safety in Korean Melanoma Patients from the Korean Named-Patient Program Cohort

Minkyu Jung, Jeeyun Lee, Tae Min Kim, Dae Ho Lee, Jin Hyung Kang, Sung Young Oh, Soo Jung Lee, Sang Joon Shin

Cancer Res Treat. 2017;49(1):44-53. Published online April 27, 2016 DOI: https://doi.org/10.4143/crt.2016.024

Web of Science 27 Crossref 25

Systemic Treatments for Metastatic Renal Cell Carcinoma: 10-Year Experience of Immunotherapy and Targeted Therapy

Sung Han Kim, Weon Seo Park, Sun Ho Kim, Jae Young Joung, Ho Kyung Seo, Kang Hyun Lee, Jinsoo Chung

Cancer Res Treat. 2016;48(3):1092-1101. Published online January 28, 2016 DOI: https://doi.org/10.4143/crt.2015.316

Web of Science 22 Crossref 23

Improved Efficacy of a Dendritic Cell-Based Vaccine against a Murine Model of Colon Cancer: The Helper Protein Effect

Amir-Hassan Zarnani, Monireh Torabi-Rahvar, Mahmood Bozorgmehr, Mehri Zareie, Nazanin Mojtabavi

Cancer Res Treat. 2015;47(3):518-526. Published online November 27, 2014 DOI: https://doi.org/10.4143/crt.2013.241

Web of Science 12 Crossref 10

Alpha-Type 1 Polarized Dendritic Cells Loaded with Apoptotic Allogeneic Breast Cancer Cells Can Induce Potent Cytotoxic T Lymphocytes against Breast Cancer

Min-Ho Park, Deok-Hwan Yang, Mi-Hyun Kim, Jae-Hong Jang, Yoon-Young Jang, Youn-Kyung Lee, Chun-Ji Jin, Than Nhan Nguyen Pham, Truc Anh Nguyen Thi, Mi-Seon Lim, Hyun-Ju Lee, Cheol Yi Hong, Jung-Han Yoon, Je-Jung Lee

Cancer Res Treat. 2011;43(1):56-66. Published online March 31, 2011 DOI: https://doi.org/10.4143/crt.2011.43.1.56

Crossref 11

The Effect of Immunotherapy Based on Interferon - alpha in Advanced Renal Cell Carcinoma

Seung Hyun Jeon, Sung Goo Chang

J Korean Cancer Assoc. 1999;31(5):986-994.

Immunoregulatory Effect of Mesima (R) as an Immunotherapeutic Agent in Stage III Gastric Cancer Patients after Radical Gastrectomy

Jin Pok Kim, Keon Young Lee, Hang Jong Yu, Han Kwang Yang

J Korean Cancer Assoc. 1997;29(3):383-390.

Contribution of Enhanced Locoregional Control to Improved Overall Survival with Consolidative Durvalumab After Concurrent Chemoradiotherapy in Locally Advanced Non-Small Cell Lung Cancer: Insights from Real-World Data

Jeong Yun Jang, Si Yeol Song, Young Seob Shin, Ha Un Kim, Eun Kyung Choi, Sang-We Kim, Jae Cheol Lee, Dae Ho Lee, Chang-Min Choi, Shinkyo Yoon, Su Ssan Kim

Received September 6, 2023 Accepted January 14, 2024 Published online January 16, 2024
DOI: https://doi.org/10.4143/crt.2023.1014
[Accepted]